| Year |
Citation |
Score |
| 2023 |
Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, ... ... Leuchter AF, et al. A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression. Psychiatry Research. 330: 115608. PMID 37984281 DOI: 10.1016/j.psychres.2023.115608 |
0.341 |
|
| 2023 |
Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke SA, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Leuchter MK, Strouse TB, Corse A, Vyas P, ... Leuchter AF, et al. Pretreatment pupillary reactivity is associated with differential early response to 10 Hz and intermittent theta-burst repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD). Brain Stimulation. PMID 37863389 DOI: 10.1016/j.brs.2023.10.006 |
0.333 |
|
| 2023 |
Tadayonnejad R, Citrenbaum C, Ngo TDP, Corlier J, Wilke SA, Slan A, Distler MG, Hoftman G, Adelekun AE, Leuchter MK, Koek RJ, Ginder ND, Krantz D, Artin H, Strouse T, ... ... Leuchter AF, et al. Right lateral orbitofrontal cortex inhibitory transcranial magnetic stimulation for treatment of refractory mood and depression. Brain Stimulation. 16: 1374-1376. PMID 37716637 DOI: 10.1016/j.brs.2023.09.011 |
0.358 |
|
| 2023 |
Chu SA, Tadayonnejad R, Corlier J, Wilson AC, Citrenbaum C, Leuchter AF. Rumination symptoms in treatment-resistant major depressive disorder, and outcomes of repetitive Transcranial Magnetic Stimulation (rTMS) treatment. Translational Psychiatry. 13: 293. PMID 37684229 DOI: 10.1038/s41398-023-02566-4 |
0.412 |
|
| 2023 |
Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke S, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Strouse T, Corse A, Vyas P, Leuchter A. Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Journal of Affective Disorders. PMID 37437737 DOI: 10.1016/j.jad.2023.07.008 |
0.35 |
|
| 2022 |
Tadayonnejad R, Wilson AC, Chu SA, Corlier J, Citrenbaum C, Ngo TDP, Hovhannisyan E, Ginder ND, Levitt JG, Wilke SA, Krantz D, Bari AA, Leuchter AF. Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder. Psychiatry Research. 317: 114856. PMID 36155277 DOI: 10.1016/j.psychres.2022.114856 |
0.374 |
|
| 2022 |
Wilke SA, Johnson CL, Corlier J, Marder KG, Wilson AC, Pleman CM, Leuchter AF. Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorder. Depression and Anxiety. PMID 35389536 DOI: 10.1002/da.23255 |
0.364 |
|
| 2022 |
Mirman AM, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Ojha R, Daskalakis ZJ, Leuchter AF, Lee JC. Absence of early mood improvement as a robust predictor of rTMS nonresponse in major depressive disorder. Depression and Anxiety. PMID 34990046 DOI: 10.1002/da.23237 |
0.375 |
|
| 2021 |
Leuchter AF, Wilson AC, Vince-Cruz N, Corlier J. Novel method for identification of individualized resonant frequencies for treatment of Major Depressive Disorder (MDD) using repetitive Transcranial Magnetic Stimulation (rTMS): A proof-of-concept study. Brain Stimulation. PMID 34425244 DOI: 10.1016/j.brs.2021.08.011 |
0.334 |
|
| 2021 |
Lee JC, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Ngo D, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive Disorder. Brain Stimulation. 14: 1015-1021. PMID 34186465 DOI: 10.1016/j.brs.2021.06.008 |
0.346 |
|
| 2021 |
Voigt JD, Leuchter AF, Carpenter LL. Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis. Translational Psychiatry. 11: 330. PMID 34050123 DOI: 10.1038/s41398-021-01441-4 |
0.333 |
|
| 2020 |
Bailey NW, Krepel N, van Dijk H, Leuchter AF, Vila-Rodriguez F, Blumberger DM, Downar J, Wilson A, Daskalakis ZJ, Carpenter LL, Corlier J, Arns M, Fitzgerald PB. Resting EEG theta connectivity and alpha power to predict repetitive transcranial magnetic stimulation response in depression: A non-replication from the ICON-DB consortium. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 33223495 DOI: 10.1016/j.clinph.2020.10.018 |
0.334 |
|
| 2020 |
Lee JC, Wilson AC, Corlier J, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder. Journal of Affective Disorders. 277: 964-969. PMID 33065840 DOI: 10.1016/J.Jad.2020.09.011 |
0.376 |
|
| 2020 |
Tadayonnejad R, Wilson AC, Corlier J, Lee JC, Ginder ND, Levitt JG, Wilke SA, Marder KG, Krantz D, Bari AA, Feusner JD, Pouratian N, Leuchter AF. Sequential multi-locus transcranial magnetic stimulation for treatment of obsessive-compulsive disorder with comorbid major depression: a case series. Brain Stimulation. PMID 33065361 DOI: 10.1016/j.brs.2020.10.003 |
0.322 |
|
| 2020 |
Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial. Journal of Psychiatric Research. 124: 159-165. PMID 32169689 DOI: 10.1016/J.Jpsychires.2020.02.028 |
0.427 |
|
| 2020 |
Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial. Journal of Psychiatric Research. 124: 159-165. PMID 32169689 DOI: 10.1016/J.Jpsychires.2020.02.028 |
0.427 |
|
| 2020 |
Corlier J, Burnette E, Wilson AC, Lou JJ, Landeros A, Minzenberg MJ, Leuchter AF. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control. Journal of Affective Disorders. 265: 272-277. PMID 32090751 DOI: 10.1016/J.Jad.2020.01.068 |
0.381 |
|
| 2019 |
Corlier J, Carpenter LL, Wilson AC, Tirrell E, Gobin AP, Kavanaugh B, Leuchter AF. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Brain Stimulation. PMID 31378603 DOI: 10.1016/J.Brs.2019.07.018 |
0.34 |
|
| 2019 |
Jain FA, Connolly CG, Moore LC, Leuchter AF, Abrams M, Ben-Yelles RW, Chang SE, Ramirez Gomez LA, Huey N, Lavretsky H, Iacoboni M. Grief, Mindfulness and Neural Predictors of Improvement in Family Dementia Caregivers. Frontiers in Human Neuroscience. 13: 155. PMID 31156412 DOI: 10.3389/fnhum.2019.00155 |
0.371 |
|
| 2019 |
Corlier J, Wilson A, Hunter AM, Vince-Cruz N, Krantz D, Levitt J, Minzenberg MJ, Ginder N, Cook IA, Leuchter AF. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cerebral Cortex (New York, N.Y. : 1991). PMID 30953441 DOI: 10.1016/J.Brs.2018.12.812 |
0.492 |
|
| 2019 |
Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain and Behavior. e01275. PMID 30941915 DOI: 10.1002/Brb3.1275 |
0.376 |
|
| 2019 |
Voigt J, Carpenter L, Leuchter A. A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder. Bmc Psychiatry. 19: 13. PMID 30621636 DOI: 10.1186/S12888-018-1989-Z |
0.399 |
|
| 2019 |
Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ. Corrigendum to 'Neurophysiologic predictors of treatment response to fluoxetine in major depression'. Psychiatry Research. 95: 87. PMID 10904127 DOI: 10.1016/S0165-1781(00)00170-0 |
0.406 |
|
| 2019 |
Cook I, Wilson A, Corlier J, Leuchter A. Brain activity and clinical outcomes in adults with depression treated with synchronized transcranial magnetic stimulation (sTMS): an exploratory study Brain Stimulation. 12: 584-585. DOI: 10.1016/J.Brs.2018.12.941 |
0.411 |
|
| 2019 |
Liu Q, Wu H, Doyle J, Wilson A, Corlier J, Leuchter A. 10 Hz rTMS-induced Neural Response of Gamma Oscillations in Subgenual Anterior Cingulate Cortex (sgACC) is Anti-correlated with Left Dorsolateral Prefrontal Cortex (DLPFC) in Major Depressive Disorder Brain Stimulation. 12: 544. DOI: 10.1016/J.Brs.2018.12.797 |
0.464 |
|
| 2018 |
Philip NS, Leuchter AF, Cook IA, Massaro J, Goethe JW, Carpenter LL. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder. Depression and Anxiety. PMID 30480860 DOI: 10.1002/Da.22862 |
0.312 |
|
| 2017 |
Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 1550059417746212. PMID 29224411 DOI: 10.1177/1550059417746212 |
0.418 |
|
| 2017 |
Voigt J, Carpenter L, Leuchter A. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis. Plos One. 12: e0186950. PMID 29073256 DOI: 10.1371/Journal.Pone.0186950 |
0.46 |
|
| 2017 |
Fogelson DL, Leuchter A. Defining Treatment-Resistant Depression. Jama Psychiatry. PMID 28564677 DOI: 10.1001/Jamapsychiatry.2017.0967 |
0.423 |
|
| 2017 |
Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? International Review of Psychiatry (Abingdon, England). 1-17. PMID 28362541 DOI: 10.1080/09540261.2017.1297697 |
0.361 |
|
| 2017 |
Leuchter A, Corlier J, Cook I. O16 Shifts in mean peak oscillatory frequency during repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder Clinical Neurophysiology. 128: e185. DOI: 10.1016/J.Clinph.2017.07.027 |
0.477 |
|
| 2017 |
Leuchter A, Bissett J, Manberg P, Carpenter L, Massaro J, George M. The relationship between the individual alpha frequency (IAF) and response to synchronized transcranial magnetic stimulation (sTMS) for treatment of major depressive disorder (MDD) Brain Stimulation. 10: 492. DOI: 10.1016/J.Brs.2017.01.439 |
0.333 |
|
| 2017 |
Leuchter A, Espinoza R, Suthana N, Hunter A, Cook I. Synergistic effects of ketamine and theta burst stimulation in the treatment of major depressive disorder (MDD) Brain Stimulation. 10: 492. DOI: 10.1016/J.Brs.2017.01.438 |
0.378 |
|
| 2016 |
Leuchter AF, Hunter AM, Jain FA, Tartter M, Crump C, Cook IA. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder. Journal of Psychiatric Research. 84: 174-183. PMID 27770740 DOI: 10.1016/J.Jpsychires.2016.10.002 |
0.361 |
|
| 2016 |
Koek RJ, Schwartz HN, Scully S, Langevin JP, Spangler S, Korotinsky A, Jou K, Leuchter A. Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 26854815 DOI: 10.1016/J.Pnpbp.2016.01.015 |
0.331 |
|
| 2016 |
Cook IA, Abrams M, Leuchter AF. Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. Neuromodulation : Journal of the International Neuromodulation Society. 19: 299-305. PMID 26818103 DOI: 10.1111/Ner.12399 |
0.309 |
|
| 2016 |
Hunter AM, Leuchter AF. Changes in resting-state quantitative electroencephalography (qEEG) and symptom severity during repetitive transcranial magnetic stimulation (rTMS) treatment in major depressive disorder (MDD): Case-studies Brain Stimulation. 9: e4-e5. DOI: 10.1016/J.Brs.2016.06.017 |
0.341 |
|
| 2015 |
Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF. Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology. PMID 26319158 DOI: 10.1007/S00213-015-4047-2 |
0.406 |
|
| 2015 |
Jain FA, Hunter AM, Leuchter AF, Brooks JO. A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. The Journal of Clinical Psychiatry. 76: 327. PMID 25830451 DOI: 10.4088/Jcp.14Lr09483 |
0.341 |
|
| 2015 |
Leuchter AF, Hunter AM, Krantz DE, Cook IA. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Annals of the New York Academy of Sciences. 1344: 78-91. PMID 25809789 DOI: 10.1111/Nyas.12742 |
0.309 |
|
| 2015 |
Caudill MM, Hunter AM, Cook IA, Leuchter AF. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 46: 277-84. PMID 25258429 DOI: 10.1177/1550059414532443 |
0.413 |
|
| 2015 |
Cook I, Leuchter A, Jain F, Caudill M, Abrams M, DeGiorgio C. Effects of adjunctive trigeminal nerve stimulation in major depressive disorder in a dose-ranging trial Brain Stimulation. 8: 431. DOI: 10.1016/J.Brs.2015.01.374 |
0.353 |
|
| 2015 |
Leuchter AF, Phillips B, Jin Y, Cook IA, Feifel D, Goethe J, Husain M, Carpenter L, Thase M, Krystal A, Burke W, Howland R, Sheline Y, Jain R, Aaronson S, et al. Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder Brain Stimulation. 8: 404. DOI: 10.1016/J.Brs.2015.01.287 |
0.305 |
|
| 2014 |
Leuchter AF, Hunter AM, Krantz DE, Cook IA. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience. 16: 525-37. PMID 25733956 |
0.397 |
|
| 2014 |
Leuchter AF, Hunter AM, Tartter M, Cook IA. Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. The British Journal of Psychiatry : the Journal of Mental Science. 205: 443-9. PMID 25213159 DOI: 10.1192/Bjp.Bp.113.140343 |
0.427 |
|
| 2014 |
Jain FA, Cook IA, Leuchter AF, Hunter AM, Davydov DM, Ottaviani C, Tartter M, Crump C, Shapiro D. Heart rate variability and treatment outcome in major depression: a pilot study. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 93: 204-10. PMID 24769434 DOI: 10.1016/J.Ijpsycho.2014.04.006 |
0.383 |
|
| 2014 |
Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. Journal of Psychiatric Research. 54: 11-8. PMID 24726639 DOI: 10.1016/J.Jpsychires.2014.03.009 |
0.696 |
|
| 2014 |
Cook IA, Hunter AM, Korb AS, Leuchter AF. Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? Journal of Psychiatric Research. 53: 69-75. PMID 24630467 DOI: 10.1016/J.Jpsychires.2014.01.018 |
0.729 |
|
| 2014 |
Cook IA, Espinoza R, Leuchter AF. Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurgery Clinics of North America. 25: 103-16. PMID 24262903 DOI: 10.1016/J.Nec.2013.10.002 |
0.319 |
|
| 2013 |
Hunter AM, Cook IA, Abrams M, Leuchter AF. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Medical Hypotheses. 81: 1004-11. PMID 24112999 DOI: 10.1016/J.Mehy.2013.09.016 |
0.422 |
|
| 2013 |
Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy & Behavior : E&B. 28: 221-6. PMID 23773978 DOI: 10.1016/J.Yebeh.2013.05.008 |
0.403 |
|
| 2013 |
Hunter AM, Korb AS, Cook IA, Leuchter AF. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? The Journal of Neuropsychiatry and Clinical Neurosciences. 25: 126-33. PMID 23686030 DOI: 10.1176/Appi.Neuropsych.11110330 |
0.72 |
|
| 2013 |
Leuchter AF, Cook IA, Jin Y, Phillips B. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Frontiers in Human Neuroscience. 7: 37. PMID 23550274 DOI: 10.3389/Fnhum.2013.00037 |
0.324 |
|
| 2013 |
Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. The Journal of Clinical Psychiatry. 74: 51-6. PMID 23419226 DOI: 10.4088/Jcp.10M06813 |
0.421 |
|
| 2013 |
Jain FA, Hunter AM, Brooks JO, Leuchter AF. Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depression and Anxiety. 30: 624-30. PMID 23288666 DOI: 10.1002/Da.22045 |
0.35 |
|
| 2012 |
Leuchter A, Cook IA, Hunter AM. Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'. Journal of Psychopharmacology (Oxford, England). 26: 1162-3; author reply. PMID 22807041 DOI: 10.1177/0269881111430732 |
0.402 |
|
| 2012 |
Hunter AM, Cook IA, Leuchter AF. Does prior antidepressant treatment of major depression impact brain function during current treatment? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 711-20. PMID 22445212 DOI: 10.1016/J.Euroneuro.2012.02.005 |
0.428 |
|
| 2012 |
Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. Plos One. 7: e32508. PMID 22384265 DOI: 10.1371/Journal.Pone.0032508 |
0.367 |
|
| 2012 |
Kerber KB, Wisniewski SR, Luther JF, Leuchter AF, D'Empaire I, Trivedi MH, Rush AJ. Effects of heart disease on depression treatment: results from the COMED study. General Hospital Psychiatry. 34: 24-34. PMID 22001552 DOI: 10.1016/J.Genhosppsych.2011.08.018 |
0.317 |
|
| 2011 |
Hunter AM, Cook IA, Greenwald SD, Tran ML, Miyamoto KN, Leuchter AF. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 28: 478-82. PMID 21946361 DOI: 10.1097/Wnp.0B013E318230Da8A |
0.417 |
|
| 2011 |
Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Research. 192: 188-94. PMID 21546222 DOI: 10.1016/J.Pscychresns.2010.12.007 |
0.742 |
|
| 2010 |
Hunter AM, Cook IA, Leuchter AF. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. Journal of Clinical Psychopharmacology. 30: 748-51. PMID 21057245 DOI: 10.1097/Jcp.0B013E3181Faa474 |
0.382 |
|
| 2010 |
Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrews AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD. Biomarkers to predict antidepressant response. Current Psychiatry Reports. 12: 553-62. PMID 20963521 DOI: 10.1007/S11920-010-0160-4 |
0.326 |
|
| 2010 |
Kobak KA, Leuchter A, DeBrota D, Engelhardt N, Williams JB, Cook IA, Leon AC, Alpert J. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. Journal of Clinical Psychopharmacology. 30: 193-7. PMID 20520295 DOI: 10.1097/Jcp.0B013E3181D20912 |
0.448 |
|
| 2010 |
Farahbod H, Cook IA, Korb AS, Hunter AM, Leuchter AF. Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clinical Eeg and Neuroscience. 41: 19-23. PMID 20307012 DOI: 10.1177/155005941004100106 |
0.699 |
|
| 2010 |
Hunter AM, Muthén BO, Cook IA, Leuchter AF. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. Journal of Psychiatric Research. 44: 90-8. PMID 19631948 DOI: 10.1016/J.Jpsychires.2009.06.006 |
0.418 |
|
| 2010 |
Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, Luther JF, Fava M, Rush AJ. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychological Medicine. 40: 239-51. PMID 19493369 DOI: 10.1017/S0033291709006035 |
0.357 |
|
| 2009 |
Leuchter AF, Cook IA, Hunter AM, Korb AS. A new paradigm for the prediction of antidepressant treatment response. Dialogues in Clinical Neuroscience. 11: 435-46. PMID 20135901 |
0.71 |
|
| 2009 |
Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Research. 174: 152-7. PMID 19853417 DOI: 10.1016/J.Pscychresns.2009.04.011 |
0.488 |
|
| 2009 |
Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research. 169: 124-31. PMID 19712979 DOI: 10.1016/J.Psychres.2009.06.004 |
0.425 |
|
| 2009 |
Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research. 169: 132-8. PMID 19709754 DOI: 10.1016/J.Psychres.2009.04.004 |
0.43 |
|
| 2009 |
Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 1313-9. PMID 19539524 DOI: 10.1016/J.Clinph.2009.05.008 |
0.714 |
|
| 2009 |
Leuchter AF, Cook IA, Hunter A, Korb A. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clinical Eeg and Neuroscience. 40: 78-83. PMID 19534301 DOI: 10.1177/155005940904000207 |
0.36 |
|
| 2009 |
Hunter AM, Leuchter AF, Cook IA, Abrams M, Siegman BE, Furst DE, Chappell AS. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Medicine (Malden, Mass.). 10: 730-8. PMID 19453962 DOI: 10.1111/J.1526-4637.2009.00614.X |
0.411 |
|
| 2009 |
Hunter AM, Ravikumar S, Cook IA, Leuchter AF. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta Psychiatrica Scandinavica. 119: 266-73. PMID 19077131 DOI: 10.1111/J.1600-0447.2008.01305.X |
0.347 |
|
| 2008 |
Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical Eeg and Neuroscience. 39: 175-81. PMID 19044214 DOI: 10.1177/155005940803900405 |
0.346 |
|
| 2008 |
Korb AS, Cook IA, Hunter AM, Leuchter AF. Brain electrical source differences between depressed subjects and healthy controls. Brain Topography. 21: 138-46. PMID 18958615 DOI: 10.1007/S10548-008-0070-5 |
0.716 |
|
| 2008 |
Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. Journal of Psychiatric Practice. 14: 271-80. PMID 18832958 DOI: 10.1097/01.Pra.0000336754.19566.65 |
0.369 |
|
| 2008 |
Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. The American Journal of Psychiatry. 165: 342-51. PMID 18172020 DOI: 10.1176/Appi.Ajp.2007.06111868 |
0.471 |
|
| 2007 |
Shapiro D, Cook IA, Davydov DM, Ottaviani C, Leuchter AF, Abrams M. Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evidence-Based Complementary and Alternative Medicine : Ecam. 4: 493-502. PMID 18227917 DOI: 10.1093/ecam/nel114 |
0.347 |
|
| 2007 |
Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Fava M, Rush AJ. Insured and non-insured depressed outpatients: how do they compare? Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 73-82. PMID 17612846 DOI: 10.1080/10401230701334671 |
0.363 |
|
| 2007 |
Hunter AM, Cook IA, Leuchter AF. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. The Psychiatric Clinics of North America. 30: 105-24. PMID 17362807 DOI: 10.1016/J.Psc.2006.12.002 |
0.45 |
|
| 2007 |
Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas. 56: 54-60. PMID 16835012 DOI: 10.1016/J.Maturitas.2006.05.010 |
0.327 |
|
| 2007 |
Claassen CA, Trivedi MH, Rush AJ, Husain MM, Zisook S, Young E, Leuchter A, Wisniewski SR, Balasubramani GK, Alpert J. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. Journal of Affective Disorders. 97: 77-84. PMID 16824617 DOI: 10.1016/J.Jad.2006.05.026 |
0.421 |
|
| 2007 |
Leuchter A, Cook I, Marangell L, Gilmer W, Burgoyne K, Howland R, Trivedi M, Zisook S, Fava M, Manberg P. P.2.g.007 Biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) European Neuropsychopharmacology. 17: S394-S395. DOI: 10.1016/S0924-977X(07)70587-4 |
0.311 |
|
| 2006 |
Hunter AM, Leuchter AF, Morgan ML, Cook IA. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. The American Journal of Psychiatry. 163: 1426-32. PMID 16877657 DOI: 10.1176/Ajp.2006.163.8.1426 |
0.405 |
|
| 2006 |
Venneman S, Leuchter A, Bartzokis G, Beckson M, Simon SL, Schaefer M, Rawson R, Newton T, Cook IA, Uijtdehaage S, Ling W. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 208-16. PMID 16720798 DOI: 10.1176/Jnp.2006.18.2.208 |
0.381 |
|
| 2006 |
Moses T, Leuchter AF, Cook I, Abrams M. Does the clinical course of depression determine improvement in symptoms and quality of life? The Journal of Nervous and Mental Disease. 194: 241-8. PMID 16614544 DOI: 10.1097/01.Nmd.0000207358.15230.80 |
0.337 |
|
| 2005 |
Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ. Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatric Services (Washington, D.C.). 56: 995-1004. PMID 16088018 DOI: 10.1176/Appi.Ps.56.8.995 |
0.35 |
|
| 2005 |
Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of Psychiatric Research. 39: 461-6. PMID 15992554 DOI: 10.1016/J.Jpsychires.2004.12.002 |
0.442 |
|
| 2005 |
Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology. 52: 71-6. PMID 15990459 DOI: 10.1159/000086608 |
0.367 |
|
| 2005 |
Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. The Journal of Clinical Psychiatry. 66: 774-80. PMID 15960574 DOI: 10.4088/Jcp.V66N0617 |
0.332 |
|
| 2005 |
Hunter AM, Leuchter AF, Morgan ML, Cook IA, Abrams M, Siegman B, DeBrota DJ, Potter WZ. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 792-9. PMID 15637637 DOI: 10.1038/Sj.Npp.1300652 |
0.322 |
|
| 2004 |
Stubbeman WF, Leuchter AF, Cook IA, Shurman BD, Morgan M, Gunay I, Gonzalez S. Pretreatment neurophysiologic function and ECT response in depression. The Journal of Ect. 20: 142-4. PMID 15342997 DOI: 10.1097/00124509-200409000-00004 |
0.373 |
|
| 2004 |
Marie-Mitchell A, Leuchter AF, Chou CP, James Gauderman W, Azen SP. Predictors of improved mood over time in clinical trials for major depression. Psychiatry Research. 127: 73-84. PMID 15261707 DOI: 10.1016/J.Psychres.2004.02.013 |
0.446 |
|
| 2004 |
Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology. 177: 15-22. PMID 15252704 DOI: 10.1007/S00213-004-1919-2 |
0.389 |
|
| 2002 |
Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 120-31. PMID 12062912 DOI: 10.1016/S0893-133X(02)00294-4 |
0.412 |
|
| 2002 |
Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. The American Journal of Psychiatry. 159: 122-9. PMID 11772700 DOI: 10.1176/Appi.Ajp.159.1.122 |
0.393 |
|
| 2001 |
Cook IA, Leuchter AF. Prefrontal changes and treatment response prediction in depression Seminars in Clinical Neuropsychiatry. 6: 113-120. PMID 11296311 DOI: 10.1053/Scnp.2001.21844 |
0.495 |
|
| 2000 |
Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. Journal of Affective Disorders. 60: 13-23. PMID 10940443 DOI: 10.1016/S0165-0327(99)00157-3 |
0.395 |
|
| 1999 |
Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SHJ, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C. Neurophysiologic predictors of treatment response to fluoxetine in major depression Psychiatry Research. 85: 263-273. PMID 10333379 DOI: 10.1016/S0165-1781(99)00010-4 |
0.378 |
|
| 1999 |
Leuchter AF, Bruce ML, Frazer A, Roose SP, Borson S. MEDICATION TREATMENT OUTCOMES IN DEPRESSION: DOES MECHANISM OF ACTION MAKE A DIFFERENCE? The American Journal of Geriatric Psychiatry. 7: 9. DOI: 10.1097/00019442-199911001-00026 |
0.341 |
|
| 1998 |
Cook IA, Leuchter AF, Uijtdehaage SHJ, Osato S, Holschneider DH, Abrams M, Rosenberg-Thompson S. Altered cerebral energy utilization in late life depression Journal of Affective Disorders. 49: 89-99. PMID 9609672 DOI: 10.1016/S0165-0327(97)00192-4 |
0.392 |
|
| 1994 |
Leuchter A, Simon SL, Daly KA, Abrams M, Rosenberg-Thompson S, Dunkin JJ, Cook IA, Newton TF, Spar JE. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part II: Two-Year Follow-Up of Patients With Depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 2: 290-299. PMID 28530979 DOI: 10.1097/00019442-199402040-00004 |
0.439 |
|
| 1994 |
Leuchter A, Simon SL, Daly KA, Rosenberg-Thompson S, Abrams M, Dunkin JJ, Cook IA, Newton TF, Walter DO, Cummings JL. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part I: Cross-Sectional and Longitudinal Assessment of Patients With Dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 2: 200-209. PMID 28530933 DOI: 10.1097/00019442-199400230-00004 |
0.346 |
|
| Show low-probability matches. |